FI972528A -
Process for the preparation of a physical form of N- (4- (5-cyclopentyloxycarbonyl) amino-1-methyl-indol-3-yl-methyl) -3-methoxybenzoyl) -2-methylbenzenesulfonamide
- Google Patents
Process for the preparation of a physical form of N- (4- (5-cyclopentyloxycarbonyl) amino-1-methyl-indol-3-yl-methyl) -3-methoxybenzoyl) -2-methylbenzenesulfonamide
Download PDF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909027014Aexternal-prioritypatent/GB9027014D0/en
Priority claimed from GB919115107Aexternal-prioritypatent/GB9115107D0/en
Priority claimed from FI915826Aexternal-prioritypatent/FI101193B/en
Application filed by Zeneca LtdfiledCriticalZeneca Ltd
Publication of FI972528ApublicationCriticalpatent/FI972528A/en
Publication of FI972528A0publicationCriticalpatent/FI972528A0/en
Application grantedgrantedCritical
Publication of FI106021BpublicationCriticalpatent/FI106021B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
The invention relates to a process for preparing a special physical form of N-[4-[5- (cyclopentyloxycarbonyl)amino-1-methylindol-3-ylmethyl]-3- methoxybenzoyl]-2-methylbenzenesulphonamide by using, as the starting material, another physical form of the same compound. The compound which is obtained in this way can be used for producing pharmaceutical compositions which can be used for treating diseases in which leukotrienes are involved, for example asthma.
FI972528A1990-12-121997-06-13Process for preparing a physical form of N-[4-[5- (cyclopentyloxycarbonyl)amino-1-methylindol-3-ylmethyl]-3- methoxybenzoyl]-2-methylbenzenesulphonamide
FI106021B
(en)
Process for preparing a physical form of N-[4-[5- (cyclopentyloxycarbonyl)amino-1-methylindol-3-ylmethyl]-3- methoxybenzoyl]-2-methylbenzenesulphonamide
compounds, process for the manufacture thereof, pharmaceutical compositions comprising them, method for treating and / or prophylaxis of diseases that are associated with cb1 receptor modulation and their use
Process for the preparation of a physical form of N- (4- (5-cyclopentyloxycarbonyl) amino-1-methyl-indol-3-yl-methyl) -3-methoxybenzoyl) -2-methylbenzenesulfonamide